Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 841–860 of 17,529 recalls

January 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 28, 2025· Ascent Consumer Products Inc.

Recalled Item: SinuCleanse Soft Tip Squeeze Bottle Nasal Wash System (sodium bicarbonate

The Issue: Microbial Contamination of Non-Sterile Products: Bacterial contamination with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
January 28, 2025· Ascent Consumer Products Inc.

Recalled Item: SinuCleanse Soft Tip NETI POT Nasal Wash System (sodium bicarbonate

The Issue: Microbial Contamination of Non-Sterile Products: Bacterial contamination with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
January 28, 2025· Ascent Consumer Products Inc.

Recalled Item: SinuCleanse Premixed SALINE PACKETS (sodium bicarbonate USP 700 mg and

The Issue: Microbial Contamination of Non-Sterile Products: Bacterial contamination with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
January 24, 2025· SKY PACKAGING

Recalled Item: HydrALAZINE Hydrochloride

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 24, 2025· RemedyRepack Inc.

Recalled Item: Carvedilol 25 mg Tablet

The Issue: CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 24, 2025· SKY PACKAGING

Recalled Item: HydrALAZINE Hydrochloride

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 23, 2025· FDC Limited

Recalled Item: Timolol Maleate Ophthalmic Solution USP

The Issue: Defective Container: Unable to get the solution out

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 22, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Carvedilol Tablets

The Issue: CGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 22, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Carvedilol Tablets

The Issue: CGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 21, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Lorazepam Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 21, 2025· Provepharm Inc.

Recalled Item: Phenylephrine HCl Injection

The Issue: Presence of Particulate Matter

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
January 21, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Lorazepam Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 21, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Lorazepam Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 21, 2025· AvKARE

Recalled Item: Irbesartan Tablets USP

The Issue: Out of Specification for Dissolution

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 17, 2025· The W.S. Badger Company, Inc.

Recalled Item: BADGER 50

The Issue: Labeling: Missing Label: The finished product potentially missing

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
January 17, 2025· McKesson

Recalled Item: Inflectra (infliximab-dyyb)

The Issue: cGMP Deviations: Product intended for quarantine was inadvertently

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 16, 2025· Appco Pharma LLC

Recalled Item: Venlafaxine Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskCompleted
Refund